Aina Yemi, Susman Jeffrey L
Combined Family Medicine-Psychiatry Program, College of Medicine, University of Cincinnati, Cincinnati, Ohio 45267-0582, USA.
J Am Osteopath Assoc. 2006 May;106(5 Suppl 2):S9-14.
Comorbidity is the rule with anxiety and depressive disorders. Anxiety and major depressive disorder are often comorbid with each other; these disorders are commonly associated with other psychiatric disorders; and they are frequently found coexisting with long-standing chronic medical conditions such as cardiovascular disease and diabetes mellitus. The comorbidity of major depressive and anxiety disorders is associated with barriers to treatment and worse psychiatric outcomes, including treatment resistance, increased risk for suicide, greater chance for recurrence, and greater utilization of medical resources. Effective recognition and treatment of anxiety and depression may be associated with functional improvement in the medical disorders (eg, lower HbA1c level in patients with diabetes). Paying careful attention to the development of anxiety and depression may also positively impact the economic burden of these disorders. To help primary care physicians better understand the comorbidity of depression and anxiety and medical disorders, the authors describe three case scenarios.
共病是焦虑症和抑郁症的常见情况。焦虑症和重度抑郁症常常相互共病;这些疾病通常与其他精神障碍相关联;并且它们经常与诸如心血管疾病和糖尿病等长期慢性疾病共存。重度抑郁症和焦虑症的共病与治疗障碍以及更差的精神科预后相关,包括治疗抵抗、自杀风险增加、复发几率更高以及医疗资源利用增加。有效识别和治疗焦虑症和抑郁症可能与躯体疾病的功能改善相关(例如,糖尿病患者的糖化血红蛋白水平降低)。密切关注焦虑症和抑郁症的发生发展也可能对这些疾病的经济负担产生积极影响。为帮助初级保健医生更好地理解抑郁症和焦虑症与躯体疾病的共病情况,作者描述了三个病例场景。